Week 96 Results of Switching from Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy to Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide among HIV/Hepatitis B Virus-Coinfected Patients
HIV/乙肝病毒合并感染患者从基于富马酸替诺福韦酯的抗逆转录病毒疗法转换为复方艾维格拉韦、考比司他、恩曲他滨和替诺福韦艾拉酚胺的疗法的第96周结果
期刊:Microbiology Spectrum
影响因子:3.8
doi:10.1128/spectrum.05125-22
Huang, Yu-Shan; Cheng, Chien-Yu; Sun, Hsin-Yun; Cheng, Shu-Hsing; Lu, Po-Liang; Lee, Chen-Hsiang; Lee, Yuan-Ti; Tsai, Hung-Chin; Yang, Chia-Jui; Liu, Chun-Eng; Liou, Bo-Huang; Lin, Shih-Ping; Huang, Sung-Hsi; Ho, Mao-Wang; Tang, Hung-Jen; Hung, Chien-Ching
